Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm
Blog

Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm

- August 21, 2021 - Dominique
Ever since hematopoietic cells grew to become “occasions” enumerated and characterised in suspension by cell counters or move cytometers, researchers and engineers have strived to refine the acquisition and show of the digital alerts generated. A big array of options was then developed to establish at finest the quite a few cell subsets that may be delineated, notably amongst hematopoietic cells. As devices grew to become increasingly secure and sturdy, the main target moved to analytic software program. Nearly concomitantly, the capability elevated to make use of massive panels (each with mass and classical cytometry) and to use synthetic intelligence/machine studying for his or her evaluation.

The mix of those ideas raised new analytical potentialities, opening an unprecedented subject of refined exploration for a lot of situations, together with hematopoiesis and hematological issues. On this assessment, the final ideas and progress achieved within the growth of recent analytical approaches for exploring high-dimensional knowledge units on the single-cell stage will likely be described as they appeared over the previous few years. A bigger and extra sensible half will element the assorted steps that should be mastered, each in knowledge acquisition and within the preanalytical test of information recordsdata.

Lastly, a step-by-step rationalization of the answer in growth to mix the Bioconductor clustering algorithm FlowSOM and the favored and broadly used software program Kaluza® (Beckman Coulter) will likely be introduced. The goal of this assessment was to level out that the day when these progresses will attain routine hematology laboratories doesn’t appear so far-off.

Detection of Immune Checkpoint Receptors – A Present Problem in Scientific Movement Cytometry

Immunological remedy ideas are more and more figuring out fashionable drugs. They’re used to deal with ailments of the immune system, for tumors, but additionally for infections, neurological ailments, and plenty of others. Most of those therapies base on antibodies, however small molecules, soluble receptors or cells and modified cells are additionally used. The event of immune checkpoint inhibitors is amazingly quick. T-cell directed antibody therapies in opposition to PD-1 or CTLA-Four are already firmly established within the clinic. Additional targets are continually being added and it’s changing into more and more clear that their expression just isn’t solely related on T cells. Moreover, we don’t but have any expertise with the long-term systemic results of the therapy.

Movement cytometry can be utilized for prognosis, monitoring, and detection of unwanted effects. On this assessment, we concentrate on checkpoint molecules as goal molecules and purposeful markers of cells of the innate and purchased immune system. Nonetheless, for many of the attention-grabbing and doubtlessly related parameters, there are nonetheless no take a look at kits appropriate for routine use. Right here we give an outline of the detection of checkpoint molecules on immune cells within the peripheral blood and present examples of a potential design of antibody panels.

The design of focused nanomedicines requires intracellular space- and time-resolved knowledge of nanoparticle distribution following uptake. Present strategies to review intracellular trafficking, akin to dynamic colocalization by fluorescence microscopy in stay cells, are normally low throughput and require in depth evaluation of enormous datasets to quantify colocalization in a number of particular person cells. Right here a way primarily based on move cytometry to simply detect and characterize the organelles through which nanoparticles are internalized and trafficked over time is proposed.

Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm

Standard cell fractionation strategies are mixed with immunostaining and high-sensitivity organelle move cytometry to get space-resolved knowledge of nanoparticle intracellular distribution. By extracting the organelles at completely different instances, time-resolved knowledge of nanoparticle intracellular trafficking are obtained. The strategy is validated by figuring out how nanoparticle measurement impacts the kinetics of arrival to the lysosomes. The outcomes reveal that this methodology permits high-throughput evaluation of nanoparticle uptake and intracellular trafficking by cells, subsequently it may be used to find out how nanoparticle design impacts their intracellular habits.

Movement cytometry knowledge mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells

The phenotype of infused cells is a serious determinant of Adoptive T-cell remedy (ACT) efficacy. But, the problem in deciphering multiparametric cytometry knowledge restricted the high quality characterization of mobile merchandise. To permit the evaluation of dynamic and sophisticated move cytometry samples we developed cytoChain, a novel dataset mining instrument and a brand new analytical workflow. CytoChain was challenged to match state-of-the-art and revolutionary tradition situations to generate stem-like reminiscence cells (TSCM ) appropriate for ACT. Noticeably, the mix of IL-7/15 and super-oxides scavenging sustained the emergence of a beforehand un-identified non-exhausted Match-TSCM signature, ignored by handbook gating and endowed with superior growth potential.

CytoChain proficiently traced again this inhabitants in unbiased datasets, and in T-cell receptor engineered lymphocytes. cytoChain flexibility and performance had been then additional validated on a broadcast dataset from circulating T cells in COVID-19 sufferers. Collectively, our outcomes assist using cytoChain to establish novel, functionally essential immunophenotypes for ACT and sufferers immunomonitoring. This text is protected by copyright. All rights reserved. Environment friendly doubled haploid (DH) plant manufacturing is of nice curiosity within the plant breeding business and analysis as a result of homozygous traces are obtained inside a single era shortening the breeding cycle considerably.

SDCCAG8 Conjugated Antibody
MBS9451587-01mLAF555 0.1mL(AF555)
EUR 480

SDCCAG8 Conjugated Antibody
MBS9451587-01mLBiotin 0.1mL(Biotin)
EUR 480

SDCCAG3 Antibody, HRP conjugated
1-CSB-PA020897LB01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against SDCCAG3. Recognizes SDCCAG3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

SDCCAG3 Antibody, HRP conjugated
MBS7108068-005mg 0.05mg
EUR 190

SDCCAG3 Antibody, HRP conjugated
MBS7108068-01mg 0.1mg
EUR 270

SDCCAG3 Antibody, HRP conjugated
MBS7108068-5x01mg 5x0.1mg
EUR 1205

SDCCAG3 Antibody, FITC conjugated
1-CSB-PA020897LC01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against SDCCAG3. Recognizes SDCCAG3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

SDCCAG3 Antibody, FITC conjugated
MBS7108069-005mg 0.05mg
EUR 190

SDCCAG3 Antibody, FITC conjugated
MBS7108069-01mg 0.1mg
EUR 270

SDCCAG3 Antibody, FITC conjugated
MBS7108069-5x01mg 5x0.1mg
EUR 1205

SDCCAG3 Conjugated Antibody
C35706 100ul
EUR 476.4

SDCCAG3 Conjugated Antibody
MBS9446171-01mLAF350 0.1mL(AF350)
EUR 480

SDCCAG3 Conjugated Antibody
MBS9446171-01mLAF405 0.1mL(AF405)
EUR 480

SDCCAG3 Conjugated Antibody
MBS9446171-01mLAF488 0.1mL(AF488)
EUR 480

SDCCAG3 Conjugated Antibody
MBS9446171-01mLAF555 0.1mL(AF555)
EUR 480

SDCCAG3 Conjugated Antibody
MBS9446171-01mLBiotin 0.1mL(Biotin)
EUR 480

SDCCAG3 Antibody, Biotin conjugated
1-CSB-PA020897LD01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against SDCCAG3. Recognizes SDCCAG3 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

SDCCAG3 Antibody, Biotin conjugated
MBS7108070-005mg 0.05mg
EUR 190

SDCCAG3 Antibody, Biotin conjugated
MBS7108070-01mg 0.1mg
EUR 270

SDCCAG3 Antibody, Biotin conjugated
MBS7108070-5x01mg 5x0.1mg
EUR 1205

SDCCAG3 Polyclonal Antibody, HRP Conjugated
A69692
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ?g
  • 50 ul
  • 100 ul

SDCCAG3 Polyclonal Antibody, FITC Conjugated
A69693
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ?g
  • 50 ul
  • 100 ul

SDCCAG3 Polyclonal Antibody, Biotin Conjugated
A69694
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ?g
  • 50 ul
  • 100 ul

SDCCAG8 Antibody
43294-100ul 100ul
EUR 302.4

SDCCAG8 Antibody
E043294 100μg/100μl
EUR 255
Description: Available in various conjugation types.

SDCCAG8 Antibody
E19-8846-1 50ug/50ul
EUR 145
Description: Available in various conjugation types.

SDCCAG8 Antibody
E19-8846-2 100ug/100ul
EUR 225
Description: Available in various conjugation types.

SDCCAG8 Antibody
1-CSB-PA020899GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against SDCCAG8. Recognizes SDCCAG8 from Human, Mouse, Rat, Zebrafish. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF

SDCCAG8 Antibody
DF8846 200ul
EUR 420

SDCCAG8 Antibody
DF8846-100ul 100ul
EUR 280

SDCCAG8 Antibody
DF8846-200ul 200ul
EUR 350

SDCCAG8 antibody
70R-20131 50 ul
EUR 289
Description: Rabbit polyclonal SDCCAG8 antibody

SDCCAG8 antibody
70R-4002 50 ug
EUR 467
Description: Rabbit polyclonal SDCCAG8 antibody raised against the N terminal of SDCCAG8

SDCCAG8 antibody
70R-4128 50 ug
EUR 467
Description: Rabbit polyclonal SDCCAG8 antibody raised against the middle region of SDCCAG8

SDCCAG8 Antibody
1-CSB-PA006722
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against SDCCAG8. Recognizes SDCCAG8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000

SDCCAG8 Antibody
ABD8846 100ug
EUR 325

SDCCAG8 Antibody
GWB-MS519F 50ug Ask for price

SDCCAG8 Antibody
GWB-MS520G 50ug Ask for price

SDCCAG8 Antibody
R36187-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Serologically defined colon cancer antigen 8

SDCCAG8 Antibody
MBS7118899-005mg 0.05mg
EUR 150

SDCCAG8 Antibody
MBS7118899-01mg 0.1mg
EUR 190

SDCCAG8 Antibody
MBS7118899-5x01mg 5x0.1mg
EUR 845

SDCCAG8 Antibody
MBS8517857-005mg 0.05mg
EUR 235

SDCCAG8 Antibody
MBS8517857-01mg 0.1mg
EUR 305

SDCCAG8 Antibody
MBS8517857-01mLAF405M 0.1mL(AF405M)
EUR 465

SDCCAG8 Antibody
MBS8517857-01mLAF546 0.1mL(AF546)
EUR 465

SDCCAG8 Antibody
MBS8517857-01mLAF750 0.1mL(AF750)
EUR 465

SDCCAG8 Antibody
MBS9415749-01mL 0.1mL
EUR 305

SDCCAG8 Antibody
MBS9415749-5x01mL 5x0.1mL
EUR 1230

SDCCAG8 Antibody
MBS9609163-01mL 0.1mL
EUR 260

SDCCAG8 Antibody
MBS9609163-02mL 0.2mL
EUR 305

SDCCAG8 Antibody
MBS9609163-5x02mL 5x0.2mL
EUR 1220

anti- SDCCAG8 antibody
FNab07666 100µg
EUR 606.3
Description: Antibody raised against SDCCAG8

SDCCAG8 Antibody (N-term)
MBS9202095-008mL 0.08mL
EUR 210

SDCCAG8 Antibody (N-term)
MBS9202095-04mL 0.4mL
EUR 430

SDCCAG8 Antibody (N-term)
MBS9202095-5x04mL 5x0.4mL
EUR 1910

SDCCAG8 Polyclonal Antibody
MBS9238144-01mL 0.1mL
EUR 415

SDCCAG8 Polyclonal Antibody
MBS9238144-5x01mL 5x0.1mL
EUR 1841

SDCCAG8 antibody - middle region
MBS3210669-01mL 0.1mL
EUR 455

SDCCAG8 antibody - middle region
MBS3210669-5x01mL 5x0.1mL
EUR 1995

OAGA06280-100UL - SDCCAG8 Antibody
OAGA06280-100UL 100ul
EUR 369

Polyclonal SDCCAG8 Antibody (Internal)
APG01216G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SDCCAG8 (Internal). This antibody is tested and proven to work in the following applications:

SDCCAG8 antibody - N-terminal region
MBS3210668-01mL 0.1mL
EUR 455

SDCCAG8 antibody - N-terminal region
MBS3210668-5x01mL 5x0.1mL
EUR 1995

SDCCAG8 Rabbit Polyclonal Antibody
E10G05684 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

SDCCAG8 Rabbit Polyclonal Antibody
E10G12558 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Polyclonal SDCCAG8 Antibody (aa469-483)
APG01240G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SDCCAG8 (aa469-483). This antibody is tested and proven to work in the following applications:

Anti-NY-CO-8 SDCCAG8 Antibody
A06824-1 100ul
EUR 380
Description: Boster Bio Anti-NY-CO-8 SDCCAG8 Antibody catalog # A06824-1. Tested in ELISA, IHC applications. This antibody reacts with Human, Mouse.

Polyclonal SDCCAG8 Antibody (internal region)
APG00810G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SDCCAG8 (internal region). This antibody is tested and proven to work in the following applications:

SDCCAG8 Antibody (N-term) Blocking Peptide
MBS9222593-INQUIRE INQUIRE Ask for price

SDCCAG8
CSB-CL020899HU 10 μg plasmid + 200μl Glycerol Ask for price

ARP52216_P050-25UL - SDCCAG8 Antibody - middle region
ARP52216_P050-25UL 25ul
EUR 99

OAEB02937-100UG - SDCCAG8 Antibody - middle region
OAEB02937-100UG 100ug
EUR 349

ARP52216_P050 - SDCCAG8 antibody - middle region (ARP52216_P050)
ARP52216_P050 100ul
EUR 389

ARP52215_P050-25UL - SDCCAG8 Antibody - N-terminal region
ARP52215_P050-25UL 25ul
EUR 99

ARP52215_P050 - SDCCAG8 antibody - N-terminal region (ARP52215_P050)
ARP52215_P050 100ul
EUR 389

SDCCAG8 siRNA
20-abx932704
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

SDCCAG8 siRNA
20-abx932705
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

SDCCAG8 Peptide
43-022P 0.1 mg
EUR 405.6
Description: SDCCAG8 Peptide

SDCCAG8 Peptide
43-023P 0.1 mg
EUR 405.6
Description: SDCCAG8 Peptide

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx121727
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx115458
  • Ask for price
  • Ask for price
  • 150 ul
  • 50 ul

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx029545-400ul 400 ul
EUR 627.6

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx029545-80l 80 µl
EUR 343.2

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
20-abx325189
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432203-200ul 200 ul
EUR 460.8

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432204-200ul 200 ul
EUR 343.2

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx237666-100ug 100 ug
EUR 577.2

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx115458-100l 100 µl
EUR 612.5

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx029545-400l 400 µl
EUR 518.75

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx237666-100g 100 µg
EUR 350

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx325189-100g 100 µg
EUR 250

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx325189-50g 50 µg
EUR 187.5

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432203-100g 100 µg
EUR 387.5

Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Antibody
abx432204-100g 100 µg
EUR 387.5

SDCCAG8 (untagged)-Human serologically defined colon cancer antigen 8 (SDCCAG8)
SC314504 10 µg Ask for price

Polyclonal SDCCAG8 (aa469-483) Antibody (internal region)
APG00811G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human SDCCAG8 (aa469-483) (internal region). This antibody is tested and proven to work in the following applications:

Sdccag8 (untagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8), (10ug)
MC221021 10 µg Ask for price

SDCCAG8 (GFP-tagged) - Human serologically defined colon cancer antigen 8 (SDCCAG8)
RG217089 10 µg Ask for price

SDCCAG8 cDNA Clone
MBS1272050-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 370

SDCCAG8 cDNA Clone
MBS1272050-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 1625

SDCCAG8 siRNA (Mouse)
MBS8226753-15nmol 15nmol
EUR 405

SDCCAG8 siRNA (Mouse)
MBS8226753-30nmol 30nmol
EUR 565

SDCCAG8 siRNA (Mouse)
MBS8226753-5x30nmol 5x30nmol
EUR 2450

SDCCAG8 siRNA (Human)
MBS8214868-15nmol 15nmol
EUR 405

SDCCAG8 siRNA (Human)
MBS8214868-30nmol 30nmol
EUR 565

SDCCAG8 siRNA (Human)
MBS8214868-5x30nmol 5x30nmol
EUR 2450

Sdccag8 (Myc-DDK-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8)
MR217262 10 µg Ask for price

Sdccag8 (GFP-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8), (10ug)
MG217262 10 µg Ask for price

SDCCAG8 (Myc-DDK-tagged)-Human serologically defined colon cancer antigen 8 (SDCCAG8)
RC217089 10 µg Ask for price

SDCCAG8 cloning plasmid
CSB-CL020899HU-10ug 10ug
EUR 495.6
Description: A cloning plasmid for the SDCCAG8 gene.

SDCCAG8 Blocking Peptide
33R-3716 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SDCCAG8 antibody, catalog no. 70R-4002

SDCCAG8 Blocking Peptide
33R-4109 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SDCCAG8 antibody, catalog no. 70R-4128

SDCCAG8 Blocking Peptide
20-abx161437
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

SDCCAG8 Blocking Peptide
DF8846-BP 1mg
EUR 234

SDCCAG8 Blocking Peptide
MBS8223011-1mg 1mg
EUR 190

SDCCAG8 Blocking Peptide
MBS8223011-5mg 5mg
EUR 345

SDCCAG8 Blocking Peptide
MBS8223011-5x5mg 5x5mg
EUR 1465

SDCCAG8 Blocking Peptide
MBS9627868-1mg 1mg
EUR 380

SDCCAG8 Blocking Peptide
MBS9627868-5x1mg 5x1mg
EUR 1650

Sdccag8 (untagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), (10 ug)
RN202374 10 µg Ask for price

Recombinant Human SDCCAG8
MBS7614701-005mg 0.05mg
EUR 470

Recombinant Human SDCCAG8
MBS7614701-02mg 0.2mg
EUR 885

Recombinant Human SDCCAG8
MBS7614701-1mg 1mg
EUR 2540

Recombinant Human SDCCAG8
MBS7614701-5x1mg 5x1mg
EUR 9820

SDCCAG8 Immunizing Peptide
MBS427918-01mg 0.1mg
EUR 225

SDCCAG8 Immunizing Peptide
MBS428077-01mg 0.1mg
EUR 225

Human SDCCAG8 ELISA KIT
ELI-29645h 96tests
EUR 696

Mouse Sdccag8 ELISA KIT
ELI-13424m 96tests
EUR 736

Human SDCCAG8 ELISA KIT
EF002773 96tests
EUR 566

Mouse SDCCAG8 shRNA Plasmid
20-abx978693
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human SDCCAG8 shRNA Plasmid
20-abx957365
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Sdccag8 (Myc-DDK-tagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), (10 ug)
RR202374 10 µg Ask for price

Human SDCCAG8 Protein Lysate
MBS8419151-002mg 0.02mg
EUR 545

Human SDCCAG8 Protein Lysate
MBS8419151-5x002mg 5x0.02mg
EUR 2225

SDCCAG8 Peptide - middle region
MBS3235624-01mg 0.1mg
EUR 180

SDCCAG8 Peptide - middle region
MBS3235624-5x01mg 5x0.1mg
EUR 730

Lenti ORF clone of Sdccag8 (mGFP-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8)
MR217262L4 10 µg Ask for price

SDCCAG8 Recombinant Protein (Rat)
RP227798 100 ug Ask for price

SDCCAG8 Recombinant Protein (Human)
RP096258 100 ug Ask for price

SDCCAG8 Recombinant Protein (Mouse)
RP170432 100 ug Ask for price

Sdccag8 ORF Vector (Rat) (pORF)
ORF075934 1.0 ug DNA
EUR 607.2

Lenti ORF clone of Sdccag8 (Myc-DDK-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8)
MR217262L3 10 µg Ask for price

SDCCAG8 ORF Vector (Human) (pORF)
ORF032087 1.0 ug DNA
EUR 486

Sdccag8 ORF Vector (Mouse) (pORF)
ORF056812 1.0 ug DNA
EUR 607.2

Human SDCCAG8 knockout cell line
ABC-KH13467 1 vial Ask for price
Description: Human SDCCAG8 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Human SDCCAG8 knockdown cell line
ABC-KD13467 1 vial Ask for price
Description: Human SDCCAG8 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

Human SDCCAG8 Protein Lysate 20ug
IHUSDCCAG8PLLY20UG each
EUR 361
Description: Human SDCCAG8 Protein Lysate 20ug

SDCCAG8 (NM_006642) Human Over-expression Lysate
LS010806 100ug
EUR 960
Description: Transient overexpression lysate of serologically defined colon cancer antigen 8 (SDCCAG8)

Rabbit anti-Danio rerio (Zebrafish)(Brachydanio rerio) Sdccag8 Polyclonal Antibody
MBS7178362-INQUIRE INQUIRE Ask for price

Lenti ORF clone of Sdccag8 (mGFP-tagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), (10 ug)
RR202374L4 10 µg Ask for price

SDCCAG8 Peptide - N-terminal region
MBS3235623-01mg 0.1mg
EUR 180

SDCCAG8 Peptide - N-terminal region
MBS3235623-5x01mg 5x0.1mg
EUR 730

Lenti ORF particles, Sdccag8 (GFP-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8), 200ul, >10^7 TU/mL
MR217262L4V 200 µl Ask for price

Lenti ORF particles, SDCCAG8 (mGFP-tagged) - Human serologically defined colon cancer antigen 8 (SDCCAG8), 200ul, >10^7 TU/mL
RC217089L4V 200 µl Ask for price

Recombinant Human SDCCAG8, GST-tagged
SDCCAG8-2552H 25ug
EUR 255.2
Description: The protein is stored in PBS buffer at -20℃. Avoid repeated freezing and thawing cycles.

Lenti ORF clone of Sdccag8 (Myc-DDK-tagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), (10 ug)
RR202374L3 10 µg Ask for price

Lenti ORF particles, SDCCAG8 (Myc-DDK tagged) - Human serologically defined colon cancer antigen 8 (SDCCAG8), 200ul, >10^7 TU/mL
RC217089L3V 200 µl Ask for price

Lenti ORF particles, Sdccag8 (GFP-tagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), 200ul, >10^7 TU/mL
RR202374L4V 200 µl Ask for price

OCOA12012-20UG - SDCCAG8 Protein Lysate
OCOA12012-20UG 20ug
EUR 269

Lenti ORF particles, Sdccag8 (Myc-DDK-tagged) - Mouse serologically defined colon cancer antigen 8 (Sdccag8), 200ul, >10^7 TU/mL
MR217262L3V 200 µl Ask for price

Lenti ORF particles, Sdccag8 (Myc-DDK-tagged ORF) - Rat serologically defined colon cancer antigen 8 (Sdccag8), 200ul, >10^7 TU/mL
RR202374L3V 200 µl Ask for price

Sdccag8 3'UTR GFP Stable Cell Line
TU168462 1.0 ml Ask for price

Sdccag8 3'UTR GFP Stable Cell Line
TU270027 1.0 ml Ask for price

SDCCAG8 3'UTR GFP Stable Cell Line
TU072786 1.0 ml
EUR 1672.8

Sdccag8 sgRNA CRISPR Lentivector set (Rat)
K7466701 3 x 1.0 ug
EUR 406.8

SDCCAG8, NT (SDCCAG8, CCCAP, Serologically defined colon cancer antigen 8, Antigen NY-CO-8, Centrosomal colon cancer autoantigen protein)
MBS6009836-02mL 0.2(mL
EUR 695

DH protocol growth is usually a time- and resource-consuming course of resulting from quite a few components affecting its success and effectivity. Right here we current ideas and examples about how essential success components might be recognized all through a DH protocol and an early microspore response monitored by easy impedance move cytometry (IFC) measurements, which can assist to optimize every step of an androgenesis-based DH protocol.

Leave a Reply

Your email address will not be published. Required fields are marked *